Trademark: 87817321
Word
NEURIMMUNE
Status
Registered
Status Code
700
Status Date
Tuesday, November 17, 2020
Serial Number
87817321
Registration Number
6197816
Registration Date
Tuesday, November 17, 2020
Mark Type
4000
Filing Date
Friday, March 2, 2018
Published for Opposition
Tuesday, September 1, 2020

Trademark Owner History
Neurimmune Holding AG - Original Registrant

Classifications
5 pharmaceutical preparations for treating diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations for treating diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapeutic purposes; pharmaceutical agents for the removal of tumors; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations, namely, immunogens; pharmaceutical preparations, namely, antibodies for use in disease testing; vaccines; diagnostic preparations for medical purposes in the form of epitopes for detection of anomalies in proteins; pharmaceutical preparations, namely, synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biological pharmaceutical preparations for medical use being for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biocides; diagnostic preparations for medical and veterinary purposes; sanitary towels for hygiene purposes; dietetic foods adapted for medical use; dietetic beverages adapted for medical use; biological preparations in the nature of protein antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases for medical purposes; antibacterial preparations, namely, antibacterial substances for medical purposes, antibacterial pharmaceuticals; biopharmaceutical preparations for the treatment of cancer; protein dietary supplements
1 chemical preparations for industrial purposes; chemical preparations for scientific purposes other than for medical or veterinary use; chemical preparations for use in photography; biological materials other than for medical or veterinary purposes, namely, biological preparations for use in industry and science; biological preparations for use in cell cultures other than for medical or veterinary use; peptide substrates used in analyzing and detecting certain toxins in chemical products and foodstuffs for clinical or medical laboratory use; polypeptides for use in diagnostic and therapeutic agents for non-medical purposes; chemical catalysts to accelerate organic reactions for biochemical processes, other than for medical or veterinary use; chemical compounds to accelerate chemical reactions; chemical preparations in the nature of activator enzymes for use in protein engineering and manufacturing
44 medical services; medical services in the field of immunity; provision of medical information; medical examinations, namely, physical examination for medical purposes; preparation of medicines, namely, pharmaceutical compounding services and dispensing of medicines in the nature of pharmaceuticals; nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care, namely, providing sanitary health care information; veterinary services; beauty salon services; care services for animals, namely, veterinary care services; hygienic care services being medical services; consultancy and provision of medical information relating to the operation, preparation, administration and dosage of pharmaceutical preparations; advisory services relating to the administration of pharmaceuticals and the preparation of pharmaceutical prescriptions by pharmacists; providing medical information to healthcare professionals and patients in the form of compiled medical reports in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals; drug use screening services for medical purposes; medical services, namely, information services relating to health care
42 monitoring, inspection, and analysis of biologically active chemical substances for quality control purposes; research on pharmaceutical products, cosmetics and foodstuffs for others; consultancy and information services in the field of monitoring and inspection for the quality control and analysis of biologically active chemical substances; research in the field of medical treatment and medical methods; research in the fields of biotechnology and antibodies; medical and scientific research information in the field of clinical trial testing and research in medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical manufacturing for quality control and scientific research purposes and research in the field of biology; computer software design; computer programming; maintenance of computer software; design and development of computer hardware; development of computer software; consultancy and provision of information relating to quality control of pharmaceutical preparations; scientific research in the field of cancerous diseases; scientific research relating to chemistry

Trademark Events
Nov 10, 2023
Teas Change Of Correspondence Received
Nov 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 21, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 21, 2022
Teas Change Of Correspondence Received
Jan 21, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 21, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 21, 2022
Teas Change Of Owner Address Received
Jul 21, 2021
Teas Change Of Correspondence Received
Jul 21, 2021
Teas Change Of Domestic Representatives Address
Jul 21, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 21, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 17, 2020
Registered-Principal Register
Sep 1, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 1, 2020
Published For Opposition
Aug 12, 2020
Notification Of Notice Of Publication E-Mailed
Jul 27, 2020
Examiner's Amendment After Pub Approval
Jul 27, 2020
Examiners Amendment E-Mailed
Jul 27, 2020
Case Returned To Examination
Jul 27, 2020
Notice Of Allowance Cancelled
Jul 21, 2020
Attorney Review/Decision On Amendment Required
Jul 21, 2020
Petition To Director - Change Basis - Granted
Jul 20, 2020
Assigned To Petition Staff
May 26, 2020
Teas Petition To Amend Basis Received
Apr 21, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 18, 2020
Sou Extension 3 Granted
Apr 18, 2020
Sou Extension 3 Filed
Apr 18, 2020
Sou Teas Extension Received
Oct 3, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 1, 2019
Sou Extension 2 Granted
Oct 1, 2019
Sou Extension 2 Filed
Oct 1, 2019
Sou Teas Extension Received
Apr 13, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 11, 2019
Sou Extension 1 Granted
Apr 11, 2019
Sou Extension 1 Filed
Apr 11, 2019
Sou Teas Extension Received
Oct 30, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 4, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 4, 2018
Published For Opposition
Aug 15, 2018
Notification Of Notice Of Publication E-Mailed
Jul 27, 2018
Approved For Pub - Principal Register
Jul 27, 2018
Examiner's Amendment Entered
Jul 27, 2018
Notification Of Examiners Amendment E-Mailed
Jul 27, 2018
Examiners Amendment E-Mailed
Jul 27, 2018
Examiners Amendment -Written
Jul 16, 2018
Teas/Email Correspondence Entered
Jul 15, 2018
Correspondence Received In Law Office
Jul 15, 2018
Teas Response To Office Action Received
Jun 22, 2018
Notification Of Non-Final Action E-Mailed
Jun 22, 2018
Non-Final Action E-Mailed
Jun 22, 2018
Non-Final Action Written
Jun 15, 2018
Assigned To Examiner
Mar 8, 2018
New Application Office Supplied Data Entered
Mar 6, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24